Filters
DoseEdge Commentary
Filtered view: All
If you don't have a login, getting started is easy.
User Commentary
What feeling does this excerpt express?
Based only on this individual comment—not the respondent's overall evaluation.
- Positive
- Neutral
- Negative
What is this excerpt about?
One comment can relate to more than one customer-experience area.
- Culture
- Promises, expectations, and proactive service
- Loyalty
- Satisfaction, recommendation, buying again, and long-term plans
- Operations
- Training, implementation, and ease of use
- Product
- Quality, capabilities, integration, and new technology
- Relationship
- Support, partnership, and executive involvement
- Value
- Money's worth, fair charging, outcomes, and expectations
How satisfied is the respondent overall?
The category comes from their Overall Score—not from the tone of this excerpt.
- 90+
- Very Satisfied
- 70–89.9
- Satisfied
- Below 70
- Dissatisfied
- 90+
- Very Satisfied
- 80–89.9
- Satisfied
- Below 80
- Dissatisfied
DoseEdge is not part of our long-term plans because Baxter is planning to sunset the product. I like...
When I think about partnership, I think about long-term innovation and a vendor's commitment to...
I would buy DoseEdge again only for the parenteral nutrition piece. The vendor has the...
Baxter is shutting DoseEdge down. In 2028, they're going to stop supporting the application. The...
Baxter has something available for training, but it isn't really in depth or aligned with current...
We have used DoseEdge for more than a decade. We have optimized and tweaked it to fit our needs, and...
We use DoseEdge, but it is being sunsetted. We are trying to find an alternative. If we happen to go...
Based on the initial implementation, I expected DoseEdge to be very difficult to train people on,...
I would buy DoseEdge again. I even advocated for some companies to actually purchase it now that it...
DoseEdge is a hard thing to implement. Baxter doesn't do anything proactively.
Commentary Summary
Comment Type Breakout